Building the Future of Biodefense

Biothreat intelligence to deter and detect natural, accidental, deliberate and novel biological agents.

ADVISORY
Suriname reports over 1,000 chikungunya cases amid a national shortage of pesticides and larvicides
02/27/2026
Suriname

Recommendation: Organizations in Suriname should reduce mosquito populations at their facilities by eliminating standing water. Employees can prevent mosquito bites by wearing protective clothing, using insect repellent, and eliminating standing water near their homes. Organizations should inform employees with planned work travel to affected countries and support pregnant employees who opt not to travel. Employees should consult a doctor about vaccination against chikungunya before traveling to affected areas. Vaccine eligibility and availability may vary by country.

Situation: Suriname health officials reported 1,150 chikungunya infections so far this year, with the virus spreading quickly and further across the country. By comparison, a 2014 outbreak saw 700 cases over 4 months, making the current outbreak far more rapid. Media sources reported that healthcare officials believe the actual number is likely much higher. Large-scale mosquito control efforts have not started yet due to insufficient pesticides and larvicides, though new shipments from Barbados and Brazil are expected. However, larvicides are still being used in some areas to fight mosquito larvae. Despite rising cases, hospitals remain able to manage patient care. Officials urged the public to help control the spread of the virus by removing stagnant water, wearing protective clothing, using repellents, and sleeping under mosquito nets. Earlier in the month, the US CDC issued a Level 2: Practice Enhanced Precautions travel advisory due to the chikungunya outbreak in Suriname (see PHC alert 2/6). See PHC alerts 2/11, 2/6, 1/30, and 1/22 for earlier info. [Confidence: Very High]

ADVISORY
A study estimates that measles cost over $244 million in the US in 2025, with 32% of the cost due to lost productivity
02/27/2026
United States of America

Recommendation: Informational update only.

Situation: A recent non-peer-reviewed study estimated the economic burden of measles in the US in 2025. The study found that measles cost more than $244 million in the US last year. Nearly two-thirds of the cost was due to outbreak response activities, while less than one-third of the costs were due to productivity loss. Direct medical expenses comprised 3% of costs. If measles vaccination coverage were to decline by 1% each year, annual costs could reach $1.5 billion in 2030. [Confidence: Very High]

WATCH
The US surpasses 1,000 measles cases in the first 2 months of 2026
02/27/2026
United States of AmericaUnited States of America, PennsylvaniaUnited States of America, MinnesotaTexas, El Paso County

Recommendation: Organizations in the United States should provide flexible work schedules to support employees making vaccine appointments for themselves or family members. Measles is highly contagious and can quickly spread among unvaccinated individuals in a work environment.

Situation: The US confirmed 1,130 measles cases across 28 states so far this year, excluding cases in international travelers to the US. Within the first 2 months of 2026, the country recorded just over half of all cases reported in all of 2025 (2,256). This week, additional cases were recorded in Pennsylvania and Minnesota, increasing the state totals to 12 and 10 cases, respectively (see PHC alert on 2/23). In Texas, 4 cases were confirmed in El Paso, as well as 13 additional cases at the East Montana federal ICE facility outside of the city, according to media sources. [Confidence: Very High]

ADVISORY
Respiratory syncytial virus activity is high across the US, as hospitalizations rise among infants
02/26/2026
United States of America

Recommendation: Respiratory syncytial virus (RSV) and other respiratory illnesses are expected to impact employee absenteeism due to illness or caregiving duties. Organizations in the United States (US) should provide flexible work schedules to support employees making vaccine appointments for themselves or family members.

Situation: The WastewaterSCAN Dashboard reported that RSV detections in wastewater were High on average throughout the US. According to the CDC, RSV activity is elevated at Moderate levels and increasing in many areas of the country, including emergency department visits among infants and children aged 4 years old and younger. Hospitalizations are highest among infants less than 1 year old. Proper handwashing and respiratory hygiene should be reinforced, and vaccination encouraged. [Confidence: Very High]

ADVISORY
Australia records its deadliest influenza year of this century in 2025
02/26/2026
Australia

Recommendation: Influenza and other respiratory infections can impact employee absenteeism due to illness or caregiving duties. Organizations in Australia should provide flexible work schedules to support employees making vaccine appointments for themselves or family members.

Situation: Australia recorded its highest number of influenza-related deaths this century in 2025, with 1,701 deaths, surpassing the previous record set in 2017, with 1,656 deaths. Influenza-related death rose sharply from 2023 (611 deaths) and 2024 (1,045 deaths), with peaks in July 2025 and an unusual spike late in the year. According to media sources, over 500,000 lab-confirmed influenza cases were reported last year, reflecting an intense and prolonged flu season. Health officials partly linked the surge to stalled vaccination rates, particularly among young children and older adults, whose coverage fell to its lowest levels since 2020 and 2021. Officials stated that vaccine hesitancy and misinformation are contributing factors and stressed that annual influenza vaccination remains the best protection, especially for vulnerable groups. [Confidence: Very High]

Real-time,
World-wide
Biothreat Alerts

Delivered to you at the speed of relevance

Operational and strategic intelligence for biodefense

Leverage operational biosurveillance to anticipate and assess biological risks, drive decision-making, and protect mission-critical operations.

We are excited to show you the PHC Pharos Platform in action!

Enter your contact information and we'll reach out to schedule a demo.

Scroll to Top